Human Phenotype Ontology 
Grandparent Node:
expand
Purpura (HP:0000979)help
Parent Node:
expand
Macular purpura (HP:0031365)help
..Starting node
..expand
Ecchymosis (HP:0031364)help
Term ID: 31364
Name: Ecchymosis
Synonym: Ecchymoses
Definition: A purpuric lesion that is larger than 1 cm in diameter.
Comments:
Reference: HP:0031364
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandPetechiae (HP:0000967) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0031364HP:0031364Ecchymosis0AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.95
HP:0031364HP:0031364Ecchymosis0ATRX CL E G H546886ORPHA:96253Cushing disease169
HP:0031364HP:0031364Ecchymosis0BCOR CL E G H5488020893ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent101
HP:0031364HP:0031364Ecchymosis0BRAF CL E G H6731097ORPHA:96253Cushing disease276
HP:0031364HP:0031364Ecchymosis0CALR CL E G H8111455ORPHA:824Primary myelofibrosisHP:0040283 - Occasional1
HP:0031364HP:0031364Ecchymosis0CD109 CL E G H13522821685ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional
HP:0031364HP:0031364Ecchymosis0CDH23 CL E G H6407213733ORPHA:96253Cushing disease636
HP:0031364HP:0031364Ecchymosis0CHST14 CL E G H11318924464OMIM:601776Ehlers-Danlos syndrome, musculocontractural type 1.27
HP:0031364HP:0031364Ecchymosis0COL1A1 CL E G H12772197ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional373
HP:0031364HP:0031364Ecchymosis0COL3A1 CL E G H12812201OMIM:130050Ehlers-Danlos syndrome, Vascular type749
HP:0031364HP:0031364Ecchymosis0COL5A1 CL E G H12892209ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional660
HP:0031364HP:0031364Ecchymosis0COL5A2 CL E G H12902210ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional325
HP:0031364HP:0031364Ecchymosis0F13A1 CL E G H21623531ORPHA:331Congenital factor XIII deficiencyHP:0040283 - Occasional60
HP:0031364HP:0031364Ecchymosis0F13A1 CL E G H21623531OMIM:613225Factor XIII, A subunit, deficiency of.60
HP:0031364HP:0031364Ecchymosis0F13B CL E G H21653534ORPHA:331Congenital factor XIII deficiencyHP:0040283 - Occasional32
HP:0031364HP:0031364Ecchymosis0F13B CL E G H21653534OMIM:613235Factor XIIIB deficiency.32
HP:0031364HP:0031364Ecchymosis0F2 CL E G H21473535OMIM:613679Congenital prothrombin deficiency.44
HP:0031364HP:0031364Ecchymosis0FIP1L1 CL E G H8160819124ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0031364HP:0031364Ecchymosis0GBA1 CL E G H26294177ORPHA:2072Gaucher disease-ophthalmoplegia-cardiovascular calcification syndromeHP:0040284 - Very rare
HP:0031364HP:0031364Ecchymosis0GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 17.3
HP:0031364HP:0031364Ecchymosis0GGCX CL E G H26774247OMIM:277450VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1.129
HP:0031364HP:0031364Ecchymosis0GIMAP5 CL E G H5534018005OMIM:619463PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2
HP:0031364HP:0031364Ecchymosis0GP1BA CL E G H28114439OMIM:153670Bernard-Soulier syndrome, type A2, autosomal dominant.23
HP:0031364HP:0031364Ecchymosis0GP1BA CL E G H28114439ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional23
HP:0031364HP:0031364Ecchymosis0GP1BB CL E G H28124440ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional8
HP:0031364HP:0031364Ecchymosis0GP6 CL E G H5120614388OMIM:614201Bleeding disorder, platelet-type, 11.24
HP:0031364HP:0031364Ecchymosis0HPS1 CL E G H32575163OMIM:203300Hermansky-Pudlak syndrome 1121
HP:0031364HP:0031364Ecchymosis0HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 645
HP:0031364HP:0031364Ecchymosis0IFNG CL E G H34585438ORPHA:88Idiopathic aplastic anemiaHP:0040283 - Occasional23
HP:0031364HP:0031364Ecchymosis0IRF2BP2 CL E G H35994821729ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0031364HP:0031364Ecchymosis0ITGA2 CL E G H36736137ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional119
HP:0031364HP:0031364Ecchymosis0ITGA2B CL E G H36746138ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional69
HP:0031364HP:0031364Ecchymosis0ITGA2B CL E G H36746138ORPHA:849Glanzmann thrombastheniaHP:0040283 - Occasional69
HP:0031364HP:0031364Ecchymosis0ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia69
HP:0031364HP:0031364Ecchymosis0ITGB3 CL E G H36906156ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional80
HP:0031364HP:0031364Ecchymosis0ITGB3 CL E G H36906156ORPHA:849Glanzmann thrombastheniaHP:0040283 - Occasional80
HP:0031364HP:0031364Ecchymosis0JAK2 CL E G H37176192ORPHA:824Primary myelofibrosisHP:0040283 - Occasional57
HP:0031364HP:0031364Ecchymosis0MPL CL E G H43527217ORPHA:824Primary myelofibrosisHP:0040283 - Occasional97
HP:0031364HP:0031364Ecchymosis0NABP1 CL E G H6485926232ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0031364HP:0031364Ecchymosis0NPM1 CL E G H48697910ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0031364HP:0031364Ecchymosis0NR3C1 CL E G H29087978ORPHA:96253Cushing disease79
HP:0031364HP:0031364Ecchymosis0NUMA1 CL E G H49268059ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0031364HP:0031364Ecchymosis0P2RY12 CL E G H6480518124OMIM:609821Bleeding disorder, platelet-type, 8.5
HP:0031364HP:0031364Ecchymosis0PML CL E G H53719113ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent3
HP:0031364HP:0031364Ecchymosis0PRF1 CL E G H55519360ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent58
HP:0031364HP:0031364Ecchymosis0PRF1 CL E G H55519360ORPHA:88Idiopathic aplastic anemiaHP:0040283 - Occasional58
HP:0031364HP:0031364Ecchymosis0PRKAR1A CL E G H55739388ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent134
HP:0031364HP:0031364Ecchymosis0RARA CL E G H59149864ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent2
HP:0031364HP:0031364Ecchymosis0SBDS CL E G H5111919440ORPHA:88Idiopathic aplastic anemiaHP:0040283 - Occasional26
HP:0031364HP:0031364Ecchymosis0STAT3 CL E G H677411364ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent110
HP:0031364HP:0031364Ecchymosis0STAT5B CL E G H677711367ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0031364HP:0031364Ecchymosis0STX11 CL E G H867611429ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent85
HP:0031364HP:0031364Ecchymosis0STXBP2 CL E G H681311445ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent70
HP:0031364HP:0031364Ecchymosis0TBL1XR1 CL E G H7971829529ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent22
HP:0031364HP:0031364Ecchymosis0TBXA2R CL E G H691511608OMIM:614009BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT1310
HP:0031364HP:0031364Ecchymosis0TERC CL E G H701211727ORPHA:88Idiopathic aplastic anemiaHP:0040283 - Occasional48
HP:0031364HP:0031364Ecchymosis0TERT CL E G H701511730ORPHA:88Idiopathic aplastic anemiaHP:0040283 - Occasional238
HP:0031364HP:0031364Ecchymosis0TET2 CL E G H5479025941ORPHA:824Primary myelofibrosisHP:0040283 - Occasional3
HP:0031364HP:0031364Ecchymosis0TP53 CL E G H715711998ORPHA:96253Cushing disease911
HP:0031364HP:0031364Ecchymosis0UNC13D CL E G H20129423147ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent116
HP:0031364HP:0031364Ecchymosis0USP48 CL E G H8419618533ORPHA:96253Cushing disease1
HP:0031364HP:0031364Ecchymosis0USP8 CL E G H910112631ORPHA:96253Cushing disease7
HP:0031364HP:0031364Ecchymosis0USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.7
HP:0031364HP:0031364Ecchymosis0ZBTB16 CL E G H770412930ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent1


Genes (56) :AIP ATRX BCOR BRAF CALR CD109 CDH23 CHST14 COL1A1 COL3A1 COL5A1 COL5A2 F13A1 F13B F2 FIP1L1 GBA1 GFI1B GGCX GIMAP5 GP1BA GP1BB GP6 HPS1 HPS6 IFNG IRF2BP2 ITGA2 ITGA2B ITGB3 JAK2 MPL NABP1 NPM1 NR3C1 NUMA1 P2RY12 PML PRF1 PRKAR1A RARA SBDS STAT3 STAT5B STX11 STXBP2 TBL1XR1 TBXA2R TERC TERT TET2 TP53 UNC13D USP48 USP8 ZBTB16

Diseases (26) :OMIM:219090 ORPHA:96253 ORPHA:520 ORPHA:824 ORPHA:853 OMIM:601776 ORPHA:287 OMIM:130050 ORPHA:331 OMIM:613225 OMIM:613235 OMIM:613679 ORPHA:2072 OMIM:187900 OMIM:277450 OMIM:619463 OMIM:153670 OMIM:614201 OMIM:203300 OMIM:614075 ORPHA:88 ORPHA:849 OMIM:273800 OMIM:609821 ORPHA:540 OMIM:614009
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.